23 July 2010
GSK receives CHMP positive opinion for a new indication for Arixtra
21 July 2010
GlaxoSmithKline statement in response to FDA announcement on TIDE trial
21 July 2010
GSK announces Q2 results for 2010
15 July 2010
GlaxoSmithKline legal update
14 July 2010
GlaxoSmithKline statement in response to FDA Advisory Committees’ vote on safety of Avandia® (rosiglitazone)
13 July 2010
GlaxoSmithKline (GSK) responds to Senate Finance Committee letter of 12 July to FDA
09 July 2010
Data support Avandia (rosiglitazone maleate) cardiovascular safety profile
09 July 2010
GSK EU regulatory update on Avandia (rosiglitazone)
01 July 2010
GlaxoSmithKline and Genmab announce amendment to Ofatumumab agreement
Back to top

